BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China Pharmaceutical Investing
Mesoblast Operational Highlights and Financial Results for the Half-Year Ended December 31, 2017 Genetics Investing
Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results Biotech Investing
GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results Biotech Investing
MacroGenics Provides Update on Corporate Progress and 2017 Financial Results Pharmaceutical Investing
Achaogen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
